Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells.
Chebly A, Prochazkova-Carlotti M, Idrissi Y, Bresson-Bepoldin L, Poglio S, Farra C, Beylot-Barry M, Merlio JP, Tomb R, Chevret E. Chebly A, et al. Among authors: bresson bepoldin l. Front Oncol. 2021 Oct 26;11:775253. doi: 10.3389/fonc.2021.775253. eCollection 2021. Front Oncol. 2021. PMID: 34765562 Free PMC article.
Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts Clinical Outcome in Cutaneous B-Cell Lymphomas.
Menguy S, Prochazkova-Carlotti M, Azzi-Martin L, Ferté T, Bresson-Bepoldin L, Rey C, Vergier B, Merlio JP, Beylot-Barry M, Pham-Ledard A. Menguy S, et al. Among authors: bresson bepoldin l. J Invest Dermatol. 2023 Jan;143(1):124-133.e3. doi: 10.1016/j.jid.2022.06.027. Epub 2022 Aug 13. J Invest Dermatol. 2023. PMID: 35970476 Free article.
Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.
Prochazkova-Carlotti M, Gros A, Richard E, Cherrier F, Laharanne E, Idrissi Y, Baron C, Poglio S, Ducharme O, Menguy S, Pham-Ledard A, Beylot-Barry M, Merlio JP, Bresson-Bepoldin L. Prochazkova-Carlotti M, et al. Among authors: bresson bepoldin l. J Invest Dermatol. 2023 Feb;143(2):340-344.e6. doi: 10.1016/j.jid.2022.08.043. Epub 2022 Sep 7. J Invest Dermatol. 2023. PMID: 36084691 Free article. No abstract available.
A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival.
Lamaison C, Latour S, Hélaine N, Le Morvan V, Saint-Vanne J, Mahouche I, Monvoisin C, Dussert C, Andrique L, Deleurme L, Dessauge E, Pangault C, Baulande S, Legoix P, Seffals M, Broca-Brisson L, Alessandri K, Carlotti M, Soubeyran P, Merlio JP, Mourcin F, Nassoy P, Recher G, Tarte K, Bresson-Bepoldin L. Lamaison C, et al. Among authors: bresson bepoldin l. Blood Adv. 2021 Dec 14;5(23):5372-5386. doi: 10.1182/bloodadvances.2020003949. Blood Adv. 2021. PMID: 34555842 Free PMC article.
Role of Calcium Signaling in GA101-Induced Cell Death in Malignant Human B Cells.
Latour S, Zanese M, Le Morvan V, Vacher AM, Menard N, Bijou F, Durrieu F, Soubeyran P, Savina A, Vacher P, Bresson-Bepoldin L. Latour S, et al. Among authors: bresson bepoldin l. Cancers (Basel). 2019 Mar 1;11(3):291. doi: 10.3390/cancers11030291. Cancers (Basel). 2019. PMID: 30832225 Free PMC article.
Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.
Peille AL, Brouste V, Kauffmann A, Lagarde P, Le Morvan V, Coindre JM, Chibon F, Bresson-Bepoldin L. Peille AL, et al. Among authors: bresson bepoldin l. PLoS One. 2013 Nov 15;8(11):e80741. doi: 10.1371/journal.pone.0080741. eCollection 2013. PLoS One. 2013. PMID: 24260468 Free PMC article.
Does calcium contribute to the CD95 signaling pathway?
Vacher P, Khadra N, Vacher AM, Charles E, Bresson-Bepoldin L, Legembre P. Vacher P, et al. Anticancer Drugs. 2011 Jul;22(6):481-7. doi: 10.1097/CAD.0b013e32834433ea. Anticancer Drugs. 2011. PMID: 21317766 Review.
23 results